Phase II study of cisplatin and 5‐fluorouracil in previously treated metastatic breast cancer: an Eastern Cooperative Oncology Group study (PA 185)-Reference-Cited by-同舟云学术

Phase II study of cisplatin and 5‐fluorouracil in previously treated metastatic breast cancer: an Eastern Cooperative Oncology Group study (PA 185)

Published:1999-09 Issue:2 Volume:57 Page:201-206
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Kucuk Omer,Pandya Kishan J.,Skeel Roland T.,Hochster Howard,Abeloff Martin D.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.springerlink.com/index/pdf/10.1023/A:1006229701954

Reference33 articles.

1. Harris J, Morrow M, Norton L: Malignant tumors of the breast. In: DeVita VT Jr, Hellman S. Rosenberg SA (eds) Cancer: Principles and Practice of Oncology. 5th edition. Lippincott-Raven, Philadelphia, PA, 1997, pp 1557–1617

2. Miller KD, Sledge GW Jr: Taxanes in the treatment of breast cancer: A prodigy comes of age. Cancer Invest 17(2): 121–136, 1999

3. Leonard R, Rodger A, Dixon J: ABC of breast disease. Metastatic breast canccr. BMJ 309: 1501–1504, 1994

4. Tormey DC, Gelman R, Band PR, et al.: Comparison of induction chemotherapies for metastatic breast cancer: an Eastern Cooperative Oncology Group trial. Cancer 50: 1235–1244, 1982

5. Anderson NR: 5-Fluorouracil: a reappraisal of optimal delivery in advanced breast cancer. J Infusional Chemother 3: 111–118, 1993

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of therapeutic applicability and different signaling mechanism of various phytopharmacological agents for treatment of breast cancer;Biomedicine & Pharmacotherapy;2021-07

2. Emerging ways to treat breast cancer: will promises be met?;Cellular Oncology;2018-09-27

3. A phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanes;Cancer Biology & Therapy;2015-10-15

4. Platinum-Based Compounds for the Treatment of Metastatic Breast Cancer;Chemotherapy;2011

5. A phase I study of the oral platinum agent satraplatin in sequential combination with capecitabine in the treatment of patients with advanced solid malignancies;Acta Oncologica;2010-12-27